Author Archives for Adeline Chauvigné

New member | Hoppen

4 November 2025

HOPPEN develops technological tools and solutions intended to support hospitals and clinics in their digital transformation, providing concrete responses to... View Article

Owkin Closes Series A Round to Deploy Federated Learning for Research at Scale, with a Total of $70M Raised

4 November 2025

  Series A round closed with an $18 million commitment from Mubadala Investment Company’s asset management arm, Mubadala Capital in... View Article

The CE4BIG project: A European project federating four major clusters in the healthcare sector

4 November 2025

The French Atlanpole Biotherapies in Nantes is federating four major healthcare clusters aimed at fostering business growth in SMEs specialising... View Article

XENOTHERA secures funding of its anti-Covid treatment, and accelerates its product portfolio by a total amount of more than 7 million euros

4 November 2025

XENOTHERA, a Nantes-based biotech created in 2014, today announced that it has been awarded 2.3 million euros by the French Government,... View Article

i-SEP has obtained authorisations from ANSM and AFMPS to launch its clinical trial in France and Belgium

4 November 2025

I-SEP, a French MedTech (Nantes) specialising in blood processing and Patient Blood Management, has developed and patented a pioneering technology... View Article

#Coronavirus | Biofortis: providing virological and serological diagnostic tests

4 November 2025

Biofortis, a clinical research organisation specialized in nutrition and microbiota analysis, has taken all the necessary steps regarding the health... View Article

GoLiver Therapeutics Receives a Positive Scientific Advice from the European Medicines Agency (EMA)

4 November 2025

GoLiver Therapeutics Receives a Positive Scientific Advice from the European Medicines Agency (EMA) on its Clinical Development and Biomanufacturing Strategy... View Article

#Coronavirus | AtlanChim Pharma: special offer on fine Organic chemistry supporting Covid-19 Research

4 November 2025

📣 In these extraordinary circumstances ATLANCHIM PHARMA wishes to collaborate with developers of small molecules based COVID-19 #covid #chemistry For your request... View Article

New member | Odaxos

4 November 2025

  Founded in 2008 in Mayenne (France), Odaxos designs, develops and markets dental devices (dental occlusion). Since 2018, the company... View Article

New member – Vetbiobank

4 November 2025

Vetbiobank is a veterinary french biotech specialized since 2011 in the development and manufacturing of innovative animal cell-based drugs for... View Article